These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3425246)

  • 21. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device (IUCD).
    Sandvei R; Ulstein M; Wollen AL
    Acta Obstet Gynecol Scand; 1987; 66(2):131-5. PubMed ID: 3618137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structural and morphofunctional changes in the endometrium after postpartum insertion of the intrauterine device].
    Zheleznov BI; Orlova VS; Khopina AA
    Akush Ginekol (Mosk); 1982 Oct; (10):26-30. PubMed ID: 7180994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molding of the uterus following intrauterine contraceptive device removal: documentation by hysterosalpingography.
    Viglione CA; Cuttino JT; Clark RL
    Urol Radiol; 1987; 9(3):188-90. PubMed ID: 3438967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of endometriosis in women attending family planning clinics.
    Vessey MP; Villard-Mackintosh L; Painter R
    BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.
    Wollen AL; Sandvei R; Skare A; Justesen NP
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):195-9. PubMed ID: 8122497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological changes in the endometrium in direct contact with a Dana type IUD, worn for a prolonged period].
    Nesit V; Kyselá T
    Cesk Gynekol; 1972 Apr; 37(3):169-72. PubMed ID: 5023534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer in association with intrauterine contraceptive devices.
    Sugimori H; Kidera Y; Nagata Y
    Asia Oceania J Obstet Gynaecol; 1983 Mar; 9(1):31-6. PubMed ID: 6860234
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intrauterine contraceptive device as a risk factor of genital inflammatory process].
    Khadzhieva ED
    Akush Ginekol (Mosk); 1985 Aug; (9):55-6. PubMed ID: 2933984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The intrauterine device (IUD): are there still contraindications? A study of 300 Gyne-T 380 users (1987-1992)].
    Faguer C
    Contracept Fertil Sex (Paris); 1993 Jan; 21(1):23-6. PubMed ID: 12289991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights on the mode of action of intrauterine contraceptive devices in women.
    Alvarez F; Brache V; Fernandez E; Guerrero B; Guiloff E; Hess R; Salvatierra AM; Zacharias S
    Fertil Steril; 1988 May; 49(5):768-73. PubMed ID: 3360166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term effects of IUD on the human endometrium. Histologic, histochemical and ultrastructural studies.
    Lee YB; Kim CS; Ro JY; Kwak HM; Song CH
    Yonsei Med J; 1983; 24(2):141-8. PubMed ID: 6679680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sexually transmitted diseases (STD) in adolescent girls].
    Henry-suchet J
    Contracept Fertil Sex (Paris); 1987 Apr; 15(4):413-6. PubMed ID: 12315322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.